Available at: 2 YumukVTsigosCFriedMSchindlerKBusettoLMicicDet al
For patients experiencing significant gastrointestinal side effects, working with a registered dietitian can help develop strategies to maintain adequate nutrition while minimizing discomfort
Morgan Stanley estimated in 2024 that employer GLP-1 coverage generates USD 8,200 in annual healthcare cost savings per successfully treated employee with obesity generating positive ROI within 3 to 5 years
Ipamorelin is characterized as selective, producing GH release with minimal cortisol and prolactin effects, unlike GHRP-6 and GHRP-2
While emerging preclinical research suggests potential anti-inflammatory properties, there is currently no FDA-approved indication for GLP-1 medications in treating Crohn's disease or any inflammatory bowel disease
Learn the 12-week dosing schedule, manage side effects & maximize results